Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review

BACKGROUND: Pancreatic cancer is among the top 5 most common cancers worldwide, but is particularly devastating due to its insidious nature. Complete surgical resection remains the only potential curative treatment, although only 20 % of patients present with a resectable tumor. Patients may alterna...

Descripción completa

Detalles Bibliográficos
Autores principales: Gostimir, Mišo, Bennett, Sean, Moyana, Terence, Sekhon, Harman, Martel, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057443/
https://www.ncbi.nlm.nih.gov/pubmed/27724927
http://dx.doi.org/10.1186/s12885-016-2821-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057443/
https://www.ncbi.nlm.nih.gov/pubmed/27724927
http://dx.doi.org/10.1186/s12885-016-2821-0

Ejemplares similares